Prediction of Cancer Incidence and Mortality in Korea, 2019

Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Eun Sook Lee

doi:10.4143/crt.2019.139

Articles

Page Path: HOME > Cancer Res Treat > Volume 51(2); 2019 > Article

Special Article Prediction of Cancer Incidence and Mortality in Korea, 2019: Kyu-Won Jung, MS^1,2, Young-Joo Won, PhD^1,2,3,, Hyun-Joo Kong, MS^1,2, Eun Sook Lee, MD, PhD^1,4; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2019;51(2):431-437.
DOI: https://doi.org/10.4143/crt.2019.139
Published online: March 18, 2019

¹The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

²National Cancer Control Institute, National Cancer Center, Goyang, Korea

³Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

⁴Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, PhD The Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr

• Received: March 12, 2019 • Accepted: March 13, 2019

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

16,778 Views
684 Download
111 Web of Science
104 Crossref
114 Scopus

prev next

Full Article

Download PDF

Abstract
Introduction
Materials and Methods
Results
Conclusion
NOTES
REFERENCES

Abstract

Purpose
This study aimed to report on cancer incidence and mortality for the year 2019 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2017 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly; we used only the data of the latest trend.
Results
A total of 221,347 new cancer cases and 82,344 cancer deaths are expected to occur in Korea in 2019. The most common cancer sites thus far have been the lung, followed by the stomach, colon and rectum, breast, and liver. These five cancers represent half of the overall burden of cancer in Korea. For cancer associated mortality, the most common sites were lung, followed by the liver, colon and rectum, stomach, and pancreas.
Conclusion
The incidence rate of all cancer in Korea is estimated to decrease gradually. These up-todate estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.
Key words: Incidence, Mortality, Neoplasms, Forecasting, Korea, 2019

Introduction

As the leading cause of death in Korea [1], cancer has been the country’s major public health concern since 1983. Over 220,000 patients were newly diagnosed with cancer in Korea, and one in four deaths is due to cancer [2]. Although the cancer registration system in Korea is highly efficient and can provide nationwide cancer statistics within a relatively short period, a lag time of at least 2 years is required to collect and analyze data on a specific year. For planning and implementation of comprehensive cancer control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2019 based on data from the 1990s through to 2017.

Materials and Methods

The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere [3]. Incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, third edition [4], and converted according to the International Classification of Diseases, 10th edition (ICD-10) [5]. Mortality data from 1993 to 2017 were acquired from Statistics Korea [1]. The cause of death was coded and classified according to ICD-10 [5].

The cancer sites included in this study were (1) all cancers sites combined and (2) the 24 common cancer sites as follows: lips, oral cavity, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32), trachea, bronchus and lung (lung) (C33-C34), breast (C50), cervix uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C86, C96), multiple myeloma (C90), leukemia (C91-C95), and ‘other and ill defined’ sites.

Population data from 1993 to 2019 were obtained from the resident registration population data, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed. However, we used population data as of December 31, 2018 for the year 2019, because mid-2019 resident registration population data were not yet available at the time of analysis.

Linear regression models [6] were used to assess time trends and projections. We first performed a Joinpoint regression analysis on the data available to detect the year when significant changes occurred in cancer trends according to sex and cancer site. A Joinpoint regression describes changes in data trends by connecting several different line segments on a log scale at “joinpoints.” This analysis was performed using the Joinpoint software (ver. 4.3.1, http://surveillance.cancer.gov/joinpoint) from the Surveillance Research Program of the US National Cancer Institute [7]. For the analysis, we arranged to have at least four data points between consecutive joinpoints. Secondly, to predict age-specific cancer rates, a linear regression model was fitted to age-specific rates by 5-year age groups against observed years based on observed cancer incidence data of the latest trend. Finally, we multiply the projected age-specific rates by the age-specific population to get the projected cancer cases and deaths of the year 2019. For thyroid cancer, we used a square root transformation when fitting a linear regression model and converted the predicted values back to the original scale.

We summarized the results by using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population [8] and expressed per 100,000 persons.

Results

1. Incidence

A total of 221,347 new cancer cases are anticipated in 2019 (Table 1, Fig. 1), and more males (n=120,352) than females (n=100,995) are expected to be affected.

The projected CRs per 100,000 of all sites combined in 2019 are expected to be 463.5 and 390.8 in men and women, respectively (Table 2). The projected ASRs per 100,000 of all sites combined is 264.1 and 215.4 for men and women, respectively. In men, the five leading primary sites of cancer are expected to be the lung (CR, 75.9; ASR, 40.3), stomach (CR, 69.5; ASR, 38.8), colon and rectum (CR, 55.8; ASR, 30.9), prostate (CR, 51.3; ASR, 27.4), and liver (CR, 43.5; ASR, 24.3), accounting for 63.8% of all new cancers in 2019.

In women, the five leading primary sites are expected to be the breast (CR, 92.9; ASR, 58.4), colon and rectum (CR, 42.0; ASR, 18.4), stomach (CR, 35.4; ASR, 16.9), thyroid (CR, 32.9; ASR, 25.8), and lung (CR, 32.5; ASR, 14.8), accounting for 60.3% of all new cancers (Fig. 1).

The five most common cancer sites expected in 2019 by sex and age groups are shown in Table 3. Leukemia and thyroid cancer are expected to be the most common forms of cancer in both sexes for the 0-14 and 15-34 age groups. Stomach cancer is predicted to be the most prevalent cancer in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 years and above. Breast cancer is predicted to be the most common cancer in women aged 35-64 years, whereas colorectal cancer is expected to be the most prevalent in women aged 65 years and above. These projections indicate that the incidences of stomach, lung, liver, colorectal and prostate cancers will increase gradually with age for men (Fig. 2). In women, the age-specific incidence rates of stomach, colorectal, liver, lung, and cervical cancers denote a rising trend in these cancers with age; however, the incidence of breast and thyroid cancers in women is expected to level off after the age of 40.

2. Mortality

It is estimated that 82,344 cancer deaths will occur in Korea during 2019 (Table 1, Fig. 1). The projected CRs per 100,000 of all sites combined in 2019 for men and women are projected to be 193.9 and 123.8, respectively, whereas the projected ASRs per 100,000 of all sites combined are expected to be 102.7 and 49.4, respectively (Table 4). The predicted five leading cancer sites causing mortality in men are predicted to be lung (CR, 54.9; ASR, 28.0), liver (CR, 30.1; ASR, 16.3), colon and rectum (CR, 18.5; ASR, 9.8), stomach (CR, 16.8 ASR, 8.9), and pancreas (CR, 13.0; ASR, 7.0). During the same period, lung cancer (CR, 20.3; ASR, 7.5) is projected to be the leading cancer cause of death in women, followed by the colon and rectum (CR, 14.9; ASR, 5.2), pancreas (CR, 12.5; ASR, 4.7), liver (CR, 11.2; ASR, 4.2), and breast (CR, 10.5; ASR, 5.7).

The predicted age-specific mortality rates of the selected cancers for males and females in 2019 are shown in further detail in Fig. 3. When examined by age, Korean men and women aged 60 years and above are expected to have the highest mortality rates from lung cancer.

Conclusion

A total of 221,347 new cancer cases and 82,344 cancer deaths are expected to occur in Korea during 2019. Lung cancer is predicted to the most common cancer among males, followed by stomach, colorectal, prostate, and liver cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary sites are expected to be the breast, colorectal, stomach, thyroid, and lung cancers, while lung, colorectal, pancreatic, liver, and breast cancers are projected to be the most common causes of cancer-related deaths.

Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease somewhat, but burden of most of cancers will continue to grow with the increasing age of the population. The current projections of cancer incidence and mortality for 2019 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution. Specifically, the incidence of some cancers, such as stomach, colorectum, and thyroid cancers, started to decrease from early 2010s; thus, recent trends of these cancers contained only 5 or 6 data points for analysis, and therefore, their estimates could be unstable.

NOTES

Conflict of interest relevant to this article was not reported.

Acknowledgements

The authors would like to specially thank the tumor registrars (Health information manager) of the KCCR-affiliated hospitals and non-KCCR-affiliated hospitals for data collecting, abstracting, and coding. Additionally, we acknowledge the cooperation of the National Health Insurance Service and Statistics Korea for the data support.

This work was supported by the National Cancer Center research grant (No. 1910130).

Fig. 1.

The 10 leading types of estimated new cancer cases and deaths by sex in 2019. (A) Estimated new cases. (B) Estimated deaths.

Fig. 2.

Projected age-specific incidences of major cancers during 2019 in Korea. (A) Male. (B) Female.

Fig. 3.

Projected age-specific mortality rates of major cancers during 2019 in Korea. (A) Male. (B) Female.

Table 1.

Estimated new cancer cases and deaths by sex during 2019 in Korea

Site	Estimated new cases			Estimated deaths
Site	Both sexes	Male	Female	Both sexes	Male	Female
All sites	221,347	120,352	100,995	82,344	50,352	31,992
Lip, oral cavity, and pharynx	3,789	2,736	1,053	1,221	897	324
Esophagus	2,548	2,318	230	1,321	1,173	148
Stomach	27,175	18,039	9,136	6,729	4,349	2,380
Colon and rectum	25,330	14,478	10,852	8,653	4,813	3,840
Liver^a)	15,016	11,281	3,735	10,720	7,824	2,896
Gallbladder^b)	7,677	4,081	3,596	4,750	2,353	2,397
Pancreas	7,927	4,135	3,792	6,609	3,380	3,229
Larynx	1,095	1,035	60	292	292	0
Lung^c)	28,107	19,700	8,407	19,488	14,254	5,234
Breast	24,100	90	24,010	2,727	21	2,706
Cervix uteri	2,856	-	2,856	834	-	834
Corpus uteri	3,061	-	3,061	372	-	372
Ovary	2,832	-	2,832	1,271	-	1,271
Prostate	13,326	13,326	-	2,281	2,281	-
Testis	313	313	-	18	18	-
Kidney	5,609	3,794	1,815	1,189	816	373
Bladder	4,721	3,745	976	1,610	1,216	394
Brain and CNS	2,087	1,123	964	1,332	694	638
Thyroid	11,667	3,163	8,504	340	92	248
Hodgkin lymphoma	340	217	123	61	40	21
Non-Hodgkin lymphoma	5,264	3,046	2,218	2,051	1,182	869
Multiple myeloma	1,944	1,049	895	1,140	615	525
Leukemia	3,683	2,123	1,560	1,935	1,093	842
Other and ill defined	20,880	10,560	10,320	5,400	2,949	2,451

CNS, central nervous system.

^a) Includes the liver and intrahepatic bile duct,

^b) Includes the gallbladder and other/unspecified parts of the biliary tract,

^c) Includes the trachea, bronchus, and lung.

Table 2.

Estimated crude and age-standardized cancer incidences by sex during 2019 in Korea

Site	Crude incidence rate per 100,000			Age-standardized incidence rate per 100,000^a)
Site	Both sexes	Male	Female	Both sexes	Male	Female
All sites	427.2	463.5	390.8	233.5	264.1	215.4
Lip, oral cavity, and pharynx	7.3	10.5	4.1	4.2	6.2	2.4
Esophagus	4.9	8.9	0.9	2.4	4.8	0.4
Stomach	52.5	69.5	35.4	27.1	38.8	16.9
Colon and rectum	48.9	55.8	42.0	24.2	30.9	18.4
Liver^b)	29.0	43.5	14.5	14.8	24.3	6.4
Gallbladder^c)	14.8	15.7	13.9	6.7	8.4	5.4
Pancreas	15.3	15.9	14.7	7.3	8.7	6.1
Larynx	2.1	4.0	0.2	1.1	2.1	0.1
Lung^d)	54.3	75.9	32.5	25.9	40.3	14.8
Breast	46.5	0.4	92.9	29.3	0.2	58.4
Cervix uteri	5.5	0.0	11.1	3.5	-	6.9
Corpus uteri	5.9	0.0	11.8	3.6	-	7.2
Ovary	5.5	0.0	11.0	3.4	-	6.8
Prostate	25.7	51.3	0.0	12.4	27.4	-
Testis	0.6	1.2	0.0	0.6	1.2	-
Kidney	10.8	14.6	7.0	6.2	8.8	3.8
Bladder	9.1	14.4	3.8	4.3	7.7	1.6
Brain and CNS	4.0	4.3	3.7	3.0	3.4	2.6
Thyroid	22.5	12.2	32.9	17.2	9.0	25.8
Hodgkin lymphoma	0.7	0.8	0.5	0.6	0.7	0.4
Non-Hodgkin lymphoma	10.2	11.7	8.6	6.3	7.8	5.0
Multiple myeloma	3.8	4.0	3.5	1.9	2.2	1.6
Leukemia	7.1	8.2	6.0	5.5	6.5	4.6
Other and ill defined	40.3	40.7	39.9	22.1	24.8	19.7

CNS, central nervous system.

^a) Age adjusted to the world standard population,

^b) Includes the liver and intrahepatic bile duct,

^c) Includes the gallbladder and other/unspecified parts of the biliary tract,

^d) Includes the trachea, bronchus, and lung.

Table 3.

Estimated cancer incidence by age group and sex during 2019 in Korea

Rank	Age group (yr)
Rank	0-14	15-34	35-64	≥ 65
Male
1	Leukemia (5.0)	Thyroid (10.7)	Stomach (68.3)	Lung^a) (429.8)
2	Non-Hodgkin lymphoma (3.1)	Leukemia (3.7)	Colon and rectum (47.6)	Prostate (306.0)
3	Brain and CNS (2.3)	Non-Hodgkin lymphoma (3.2)	Liver^a) (47.0)	Stomach (287.8)
4	Kidney (0.4)	Testis (2.7)	Lung (43.8)	Colon and rectum (254.4)
5	Liver^b) (0.4)	Colon and rectum (2.3)	Prostate (25.9)	Liver^a) (163.1)
Female
1	Leukemia (4.3)	Thyroid (32.9)	Breast (157.2)	Colon and rectum (162.5)
2	Brain and CNS (1.9)	Breast (11.9)	Thyroid (45.9)	Lung^b) (119.5)
3	Non-Hodgkin lymphoma (1.7)	Cervix uteri (5.7)	Stomach (31.3)	Stomach (118.8)
4	Ovary (0.7)	Ovary (3.3)	Colon and rectum (29.7)	Breast (95.1)
5	Kidney (0.4)	Leukemia (2.4)	Lung^b) (25.4)	Gallbladder^c) (64.5)

CNS, central nervous system.

^a) Includes the trachea, bronchus, and lung,

^b) Includes the liver and intrahepatic bile duct,

^c) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 4.

Estimated crude and age-standardized cancer mortality rates by sex during 2019 in Korea

Site	Crude mortality rate per 100,000			Age-standardized mortality rate per 100,000^a)
Site	Both sexes	Male	Female	Both sexes	Male	Female
All sites	158.9	193.9	123.8	71.9	102.7	49.4
Lip, oral cavity, and pharynx	2.4	3.5	1.3	1.1	1.9	0.5
Esophagus	2.6	4.5	0.6	1.1	2.3	0.2
Stomach	13.0	16.8	9.2	5.7	8.9	3.3
Colon and rectum	16.7	18.5	14.9	7.3	9.8	5.2
Liver^b)	20.7	30.1	11.2	9.8	16.3	4.2
Gallbladder^c)	9.2	9.1	9.3	3.7	4.6	3.1
Pancreas	12.8	13.0	12.5	5.8	7.0	4.7
Larynx	0.6	1.1	0.0	0.2	0.6	0.0
Lung^d)	37.6	54.9	20.3	16.2	28.0	7.5
Breast	5.3	0.1	10.5	3.0	0.0	5.7
Cervix uteri	1.6	-	3.2	0.8	-	1.6
Corpus uteri	0.7	-	1.4	0.4	-	0.7
Ovary	2.5	-	4.9	1.3	-	2.4
Prostate	4.4	8.8	-	1.7	4.5	-
Testis	0.0	0.1	-	0.0	0.1	-
Kidney	2.3	3.1	1.4	1.1	1.7	0.6
Bladder	3.1	4.7	1.5	1.2	2.4	0.5
Brain and CNS	2.6	2.7	2.5	1.6	1.8	1.4
Thyroid	0.7	0.4	1.0	0.3	0.2	0.3
Hodgkin lymphoma	0.1	0.2	0.1	0.1	0.1	0.0
Non-Hodgkin lymphoma	4.0	4.6	3.4	1.8	2.5	1.3
Multiple myeloma	2.2	2.4	2.0	1.0	1.3	0.8
Leukemia	3.7	4.2	3.3	2.0	2.6	1.6
Other and ill defined	10.4	11.4	9.5	4.9	6.3	3.8

CNS, central nervous system.

^a) Age adjusted to the world standard population,

^b) Includes the liver and intrahepatic bile duct,

^c) Includes the gallbladder and other/unspecified parts of the biliary tract,

^d) Includes the trachea, bronchus, and lung.

REFERENCES

1. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2019. [cited 2019 Feb 8]. Available from: http://kosis.kr
2. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303–16. Article PubMed PMC PDF
3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. Article PubMed PMC PDF
4. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st rev. ed. Geneva: World Health Organization; 2013.
5. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. ed. Geneva: World Health Organization; 1994.
6. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon: International Agency for Research on Cancer; 1991. p. 126–58.
7. National Cancer Institute. Joinpoint regression program, version 4.3.1 [Internet]. Bethesda, MD: National Cancer Institute; 2016. [cited 2019 Feb 8]. Available from: http://surveillance.cancer.gov/joinpoint/
8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050
Mengxia Fu, Zhiming Peng, Min Wu, Dapeng Lv, Yanping Li, Shuzhen Lyu
The Breast.2025; 79: 103835. CrossRef
Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125
Amal AlSomairi, Samah Himayda, Ahmed Altelmesani, Yong Jae Lee, Jung-Yun Lee
Gynecologic Oncology.2024; 181: 155. CrossRef
Pectolinarigenin regulates the tumor-associated proteins in AGS-xenograft BALB/c nude mice
Ho Jeong Lee, Young Sang Kwon, Ju Hong Lee, Yeon Gyu Moon, Jungil Choi, Moonjung Hyun, Tae Kil Tak, Je-Hein Kim, Jeong Doo Heo
Molecular Biology Reports.2024;[Epub] CrossRef
Lowering Barriers to Health Risk Assessments in Promoting Personalized Health Management
Hayoung Park, Se Young Jung, Min Kyu Han, Yeonhoon Jang, Yeo Rae Moon, Taewook Kim, Soo-Yong Shin, Hee Hwang
Journal of Personalized Medicine.2024; 14(3): 316. CrossRef
Clinical outcomes and prognostic factors of cone‐beam CT‐guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients
Hyun Pyo Hong, Hyung Ook Kim, Dong‐Hoe Koo, Yun‐Gyoo Lee, Myung Sub Kim, Soo Youn Ham, Du‐Young Kang, Tae Yun Oh, Hyebin Lee, Kyung Uk Jung, Hungdai Kim
Asia-Pacific Journal of Clinical Oncology.2023;[Epub] CrossRef
Cost-effective BRCA Testing in Advanced Ovarian Cancer
Myungshin Kim
Annals of Laboratory Medicine.2023; 43(1): 3. CrossRef
Vaspin accelerates the proliferation, invasion and metastasis of Triple‐Negative breast cancer through MiR‐33a‐5p/ABHD2
Xin‐Hui Cao, Xiu Chen, Kai Yang, Ya‐Lin Wang, Ming‐Xing Liang, Yin‐Jiao Fei, Jin‐Hai Tang
Cancer Medicine.2023; 12(4): 4530. CrossRef
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer
Hee Jo Yang, Jae Heon Kim
Investigative and Clinical Urology.2023; 64(1): 3. CrossRef
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancer
Junhwan Kim, Joonhyung Gil, Se Ik Kim, Suhyun Hwangbo, Joseph J. Noh, Jeong-Won Lee, Gi Jeong Cheon, Jae-Weon Kim, Young Seok Cho, Maria Lee
Clinical Nuclear Medicine.2023; 48(2): e51. CrossRef
Projections of cancer mortality by 2025 in central China: A modeling study of global burden of disease 2019
Qiaohua Xu, Maigeng Zhou, Peng Yin, Donghui Jin
Heliyon.2023; 9(2): e13432. CrossRef
Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE)
Soseul Sung, Youjin Hong, Byoung‐Gie Kim, Ji‐Yeob Choi, Jae Weon Kim, Sang‐Yoon Park, Jae‐Hoon Kim, Yong‐man Kim, Jong‐Min Lee, Tae Jin Kim, Sue K. Park
Cancer Medicine.2023; 12(7): 8742. CrossRef
Effect of Sevoflurane on the Proliferation of A549 Lung Cancer Cells
Sangwon Yun, Kyongsik Kim, Keuna Shin, Hanmi Park, Sunyeul Lee, Yongsup Shin, Aung Soe Paing, Songyi Choi, Chaeseong Lim
Medicina.2023; 59(3): 613. CrossRef
Changes in the treatment rate of patients newly diagnosed with stage IV cancer near the end of life from 2012 to 2017 in Korea
Kyuwoong Kim, Hyun Jung Jho, So Jung Park, Bohyun Park, Jin Young Choi
Epidemiology and Health.2023; 45: e2023021. CrossRef
Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis
HyeJeong Jeong, Soo Yeun Lim, Hyun Jeong Jeon, So Jeong Yoon, Hongbeom Kim, In Woong Han, Jin Seok Heo, Sang Hyun Shin
ANZ Journal of Surgery.2023; 93(11): 2655. CrossRef
Mental Disorders and Suicide Risk among Cancer Patients: A Nationwide Cohort Study
Jae Woo Choi, Eun-Cheol Park, Tae Hyun Kim, Euna Han
Archives of Suicide Research.2022; 26(1): 44. CrossRef
Structural and functional brain alterations associated with cancer‐associated cognitive decline in gastric cancer patients: A preliminary longitudinal neuroimaging study
Jaeun Ahn, DeokJong Lee, Young‐Chul Jung, Kyung Ran Kim
Brain and Behavior.2022;[Epub] CrossRef
Glycosidic flavonoids and their potential applications in cancer research: a review
Abuyaseer Abusaliya, Sang Eun Ha, Pritam Bhagwan Bhosale, Hun Hwan Kim, Min Yeong Park, Preethi Vetrivel, Gon Sup Kim
Molecular & Cellular Toxicology.2022; 18(1): 9. CrossRef
A Real-World Comparative Study of Microwave and Radiofrequency Ablation in Treatment-Naïve and Recurrent Hepatocellular Carcinoma
Soon Kyu Lee, Dong Jin Chung, Se Hyun Cho
Journal of Clinical Medicine.2022; 11(2): 302. CrossRef
Recent Trends in Prostate Biopsy Complication Rates and the Role of Aztreonam in Periprocedural Antimicrobial Prophylaxis—A Nationwide Population-Based Study from Korea
Wook Nam, Min Uk Park, Han Kyu Chae, Jihye Song, Han Gwun Kim, Jong Yeon Park, Seokjoon Lee, Sung Jin Kim
Antibiotics.2022; 11(3): 312. CrossRef
Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study
Hakyoung Kim, Sae Byul Lee, Jisun Kim, Il Yong Chung, Hee Jeong Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Sei Hyun Ahn, Raffaele Serra
PLOS ONE.2022; 17(3): e0265533. CrossRef
Cost Utility Analysis of a Pilot Study for the Korean Lung Cancer Screening Project
Juyoung Kim, Bogeum Cho, Seon-Ha Kim, Chang-Min Choi, Yeol Kim, Min-Woo Jo
Cancer Research and Treatment.2022; 54(3): 728. CrossRef
The Insignificant Correlation between Androgen Deprivation Therapy and Incidence of Dementia Using an Extension Survival Cox Hazard Model and Propensity-Score Matching Analysis in a Retrospective, Population-Based Prostate Cancer Registry
Young Ae Kim, Su-Hyun Kim, Jae Young Joung, Min Soo Yang, Joung Hwan Back, Sung Han Kim
Cancers.2022; 14(11): 2705. CrossRef
Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
Journal of Korean Medical Science.2022;[Epub] CrossRef
A Comparative Analysis of Patient Satisfaction and Cosmetic Outcomes after Breast Reconstruction through BREAST-Q and the Judgment of Medical Panels: Does it Reflect Well in Terms of Aesthetics in Korean Patients?
Woo Jung Choi, Woo Jin Song, Sang Gue Kang
Archives of Plastic Surgery.2022; 49(04): 488. CrossRef
Mortality Rates and Years of Life Lost Due to Cancer in Iran: Analysis of Data from the National Death Registration System, 2016
Neda Izadi, Koorosh Etemad, Parisa Mohseni, Ardeshir Khosravi, Mohammad Esmaeil Akbari
International Journal of Cancer Management.2022;[Epub] CrossRef
Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
Song Yi Park, Koung Jin Suh, Dae-Won Lee, Han Suk Ryu, Miso Kim, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Jee Hyun Kim, In Ae Park, Seock-Ah Im
Breast Cancer Research and Treatment.2022; 196(1): 121. CrossRef
Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years
Jeongmin Lee, Youn-Ju Lee, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Min-Hee Kim
Endocrinology and Metabolism.2022; 37(4): 664. CrossRef
The Usefulness of Magnetic Resonance Imaging (MRI) for the Detection of Local Recurrence after Mastectomy with Reconstructive Surgery in Breast Cancer Patients
Jeongmin Lee, Bong Joo Kang, Ga Eun Park, Sung Hun Kim
Diagnostics.2022; 12(9): 2203. CrossRef
Colonic Chicken Skin Mucosa Surrounding Colon Polyps Is an Endoscopic Predictive Marker for Colonic Neoplastic Polyps
Yu Mi Lee, Kyung Ho Song, Hoon Sup Koo, Choong-Sik Lee, Inseok Ko, Sang Hyuk Lee, Kyu Chan Huh
Gut and Liver.2022; 16(5): 754. CrossRef
Association between gastric cancer and the family history of gastric cancer: a cross-sectional study using Korean Genome and Epidemiology Study data
Hyo Geun Choi, Wook Chun, Kuk Hyun Jung
European Journal of Cancer Prevention.2022; 31(5): 408. CrossRef
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma
Jae Hyun Kwon, Jin Wook Yi
Surgery.2021; 169(1): 43. CrossRef
Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy
Sumi Yun, Jiwon Koh, Soo Kyung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Joong Do Park, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
Cancer Immunology, Immunotherapy.2021; 70(2): 431. CrossRef
Factors influencing posttraumatic growth in ovarian cancer survivors
Jeong Min Oh, Yoonjung Kim, Yeunhee Kwak
Supportive Care in Cancer.2021; 29(4): 2037. CrossRef
Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations
Muhammad Shahid Riaz Rajoka, Hafiza Mahreen Mehwish, Yongai Xiong, Xun Song, Nazim Hussain, Qinchang Zhu, Zhendan He
Trends in Food Science & Technology.2021; 107: 240. CrossRef
Implementation effect of institutional policy of EGD observation time on neoplasm detection
Jae Myung Park, Sang Yoon Kim, Ga-Yeong Shin, Younghee Choe, Hyun Sun Cho, Chul-Hyun Lim, Yu Kyung Cho, Myung-Gyu Choi
Gastrointestinal Endoscopy.2021; 93(5): 1152. CrossRef
Glycyrrhetinic Acid-Modified Silicon Phthalocyanine for Liver Cancer-Targeted Photodynamic Therapy
Jiyoung Kim, Sanghee Lee, Kun Na
Biomacromolecules.2021; 22(2): 811. CrossRef
Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients
Kyung-In Joung, Jong Hwa Song, Kangho Suh, Seung-Mi Lee, Ji Hyun Jun, Taehwan Park, Dong Churl Suh
BioDrugs.2021; 35(1): 61. CrossRef
Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2–Targeted Agent in the Real-World Setting
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, Heejung Chae, Eo Jin Kim, Mee-Sun Moon, Yoon-Koo Kang
Cancer Research and Treatment.2021; 53(2): 436. CrossRef
Prediction of cancer incidence rates for the European continent using machine learning models
Boran Sekeroglu, Kubra Tuncal
Health Informatics Journal.2021;[Epub] CrossRef
Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study
Keyi Wang, Zonglin Wu, Guangchun Wang, Heng Shi, Jinbo Xie, Lei Yin, Tianyuan Xu, Weipu Mao, Bo Peng
International braz j urol.2021; 47(2): 333. CrossRef
Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of Coloproctology
Rumi Shin, Seongdae Lee, Kyung-Su Han, Dae Kyung Sohn, Sang Hui Moon, Dong Hyun Choi, Bong-Hyeon Kye, Hae-Jung Son, Sun Il Lee, Sumin Si, Won-Kyung Kang
Annals of Surgical Treatment and Research.2021; 100(3): 154. CrossRef
Types of cancer and outcomes in patients with cancer requiring admission from the emergency department: A nationwide, population‐based study, 2016‐2017
Youn‐Jung Kim, Dong‐Woo Seo, Won Young Kim
Cancer.2021; 127(14): 2553. CrossRef
Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals
Yong Joon Suh, Mi Jung Kwon, Hye-Mi Noh, Hong Kyu Lee, Yong Joon Ra, Nan Young Kim
Healthcare.2021; 9(4): 386. CrossRef
Traditional Korean medicine treatment for tamoxifen associated adverse events of breast cancer patient: A CARE – Compliant case report
Jihye Seo, Donghun Lee, Hee-Geun Jo
Complementary Therapies in Clinical Practice.2021; 43: 101378. CrossRef
Molecular risk markers related to local tumor recurrence at histological margin-free endoscopically resected early gastric cancers: A pilot study
Ho Suk Kang, Mi Jung Kwon, Premi Haynes, Yan Liang, Yuqi Ren, Hyun Lim, Jae Seung Soh, Nan Young Kim, Hye Kyung Lee
Pathology - Research and Practice.2021; 222: 153434. CrossRef
The Prognostic Impact of HER2 Genetic and Protein Expression in Pancreatic Carcinoma—HER2 Protein and Gene in Pancreatic Cancer
Song-Hee Han, Ki Hyun Ryu, Ah-Young Kwon
Diagnostics.2021; 11(4): 653. CrossRef
Enhancing the landscape of colorectal cancer using targeted deep sequencing
Chul Seung Lee, In Hye Song, Ahwon Lee, Jun Kang, Yoon Suk Lee, In Kyu Lee, Young Soo Song, Sung Hak Lee
Scientific Reports.2021;[Epub] CrossRef
A Modular Mobile Health App for Personalized Rehabilitation Throughout the Breast Cancer Care Continuum: Development Study
Ji Young Lim, Jong Kwang Kim, Yoon Kim, So-Yeon Ahn, Jonghan Yu, Ji Hye Hwang
JMIR Formative Research.2021; 5(4): e23304. CrossRef
Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer
Jesang Yu, Jinhong Jung, Sook Ryun Park, Min-Hee Ryu, Jin-hong Park, Jong Hoon Kim, Sang Min Yoon
BMC Cancer.2021;[Epub] CrossRef
Conditional Relative Survival of Ovarian Cancer: A Korean National Cancer Registry Study
Dong Wook Shin, Jaeman Bae, Johyun Ha, Kyu-Won Jung
Frontiers in Oncology.2021;[Epub] CrossRef
Global Patterns and Trends in Gastric Cancer Incidence Rates (1988–2012) and Predictions to 2030
Yushi Lin, Yang Zheng, Hong-liang Wang, Jie Wu
Gastroenterology.2021; 161(1): 116. CrossRef
Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy
Kyeong-Won Ryu, Jae-Moon Bae, Eun-Mee Kim, Ji Yeong An, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Robert Jeenchen Chen
PLOS ONE.2021; 16(5): e0252168. CrossRef
Histiocytic pleural effusion: the strong clue to malignancy
Ganghee Chae, Jae-Bum Jun, Hwa Sik Jung, Chui Yong Park, Jin Hyoung Kim, Byung Ju Kang, Hyeon Hui Kang, Seung Won Ra, Kwang Won Seo, Yangjin Jegal, Jong Joon Ahn, Sang Hyuk Park, Taehoon Lee
World Journal of Surgical Oncology.2021;[Epub] CrossRef
Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform
Seunghyup Jeong, Unyong Kim, Myung Oh, Jihyeon Nam, Se Park, Yoon Choi, Dong Lee, Jaehan Kim, Hyun An
Journal of Personalized Medicine.2021; 11(6): 575. CrossRef
Developing an integrated model of community-based palliative care into the primary health care (PHC) for terminally ill cancer patients in Iran
Suzanne Hojjat-Assari, Maryam Rassouli, Maxwell Madani, Heshmatolah Heydari
BMC Palliative Care.2021;[Epub] CrossRef
Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
Musaed Rayzah, Jai Min Ryu, Jun-Hee Lee, Seok Jin Nam, Seok Won Kim, Se Kyung Lee, Jonghan Yu, Kyeong-Tae Lee, Sa-Ik Bang, Goo-Hyun Mun, Jai-Kyong Pyon, Byung-Joon Jeon, Jeong Eon Lee
Journal of Korean Medical Science.2021;[Epub] CrossRef
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations
Keunchil Park, Jin-Soo Kim, Joo-Hang Kim, Young-Chul Kim, Hoon-Gu Kim, Eun Kyung Cho, Jong-Youl Jin, Miyoung Kim, Angela Märten, Jin-Hyoung Kang
BMC Cancer.2021;[Epub] CrossRef
Individual 5-Year Lung Cancer Risk Prediction Model in Korea Using a Nationwide Representative Database
Yohwan Yeo, Dong Wook Shin, Kyungdo Han, Sang Hyun Park, Keun-Hye Jeon, Jungkwon Lee, Junghyun Kim, Aesun Shin
Cancers.2021; 13(14): 3496. CrossRef
Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
Cancer Research and Treatment.2021; 53(3): 650. CrossRef
Seasonal variations in the diagnosis of the top 10 cancers in Korea: A nationwide population‐based study using a common data model
Jin Young Yoon, Min Seob Kwak, Ha Il Kim, Jae Myung Cha
Journal of Gastroenterology and Hepatology.2021; 36(12): 3371. CrossRef
The Association between Coffee Consumption and Risk of Colorectal Cancer in a Korean Population
Youngyo Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Nutrients.2021; 13(8): 2753. CrossRef
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020
Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Shaoming Wang, Ru Chen, Kexin Sun, Hongmei Zeng, Jiachen Zhou, Wenqiang Wei
Cancer Communications.2021; 41(11): 1183. CrossRef
Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
Taeyeong Eom, Yujin Lee, Jungbin Kim, Inseok Park, Geumhee Gwak, Hyunjin Cho, Keunho Yang, Kiwhan Kim, Byung-Noe Bae
Annals of Coloproctology.2021; 37(4): 259. CrossRef
Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis
Ji Woon Yea, Jae Won Park, Se An Oh, Jaehyeon Park
International Journal of Hyperthermia.2021; 38(1): 1333. CrossRef
Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution’s experience in Korea
Yeon Hee Park, Vassiliki Karantza, Shawna R. Calhoun, Seri Park, Sohee Lee, Ji-Yeon Kim, Jong Han Yu, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam, Gursel Aktan, Mark Marsico
Breast Cancer Research and Treatment.2021; 189(3): 653. CrossRef
A Real-World, Population-Based Retrospective Analysis of Therapeutic Survival for Recurrent Localized Renal Cell Carcinoma After Nephrectomy
Sung Han Kim, Min Gee Choi, Ji Hye Shin, Young-Ae Kim, Jinsoo Chung
Frontiers in Oncology.2021;[Epub] CrossRef
Closure of Petersen's Space Lowers the Incidence of Gastric Food Retention after Distal Gastrectomy with Gastrojejunostomy in Gastric Cancer Patients
Jaewon Lee, Hye Seong Ahn, Dong-Seok Han
Journal of Gastric Cancer.2021; 21(3): 298. CrossRef
Pathologic Complete Response Prediction after Neoadjuvant Chemoradiation Therapy for Rectal Cancer Using Radiomics and Deep Embedding Network of MRI
Seunghyun Lee, Joonseok Lim, Jaeseung Shin, Sungwon Kim, Heasoo Hwang
Applied Sciences.2021; 11(20): 9494. CrossRef
Gastric Signet Ring Cell Carcinoma with Metastasis to the Bone and Bone Marrow in a Patient with 12-Year-Disease-Free Interval and Unusually Long Survival Time
Hyung Woo Kim, Mi Jin Gu, Jong Ho Lee
Laboratory Medicine Online.2021; 11(4): 305. CrossRef
Volumetric change of the latissimus dorsi muscle after postoperative chemotherapy and radiotherapy in immediate breast reconstruction with an extended latissimus dorsi musculocutaneous flap: final results from serial studies
Kyeong Ho Song, Won Seok Oh, Jae Woo Lee, Min Wook Kim, Dae Kyun Jeong, Seong Hwan Bae, Hyun Yul Kim, Youn Joo Jung, Ki Seok Choo, Kyung Jin Nam, Ji Hyeon Joo, Mi Sook Yun, Su Bong Nam
Archives of Plastic Surgery.2021; 48(06): 607. CrossRef
Evaluation of Combined Cancer Markers With Lactate Dehydrogenase and Application of Machine Learning Algorithms for Differentiating Benign Disease From Malignant Ovarian Cancer
Seri Jeong, Dae-Soon Son, Minseob Cho, Nuri Lee, Wonkeun Song, Saeam Shin, Sung-Ho Park, Dong Jin Lee, Min-Jeong Park
Cancer Control.2021;[Epub] CrossRef
Evaluation of the Value of Multiplex MicroRNA Analysis as a Breast Cancer Screening in Korean Women under 50 Years of Age with a High Proportion of Dense Breasts
Ji Young Jang, Eun Young Ko, Ji Soo Jung, Kyung Nam Kang, Yeon Soo Kim, Chul Woo Kim
Journal of Cancer Prevention.2021; 26(4): 258. CrossRef
Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
Se Ik Kim, Se Jeong Kim, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim
Journal of Gynecologic Oncology.2020;[Epub] CrossRef
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K. Park, J. Vansteenkiste, K.H. Lee, G. Pentheroudakis, C. Zhou, K. Prabhash, T. Seto, P.J. Voon, D.S.W. Tan, J.C.H. Yang, J. Wang, K. Govind Babu, Y. Nakayama, A. Alip, K.L.M. Chua, J.C.-H. Cheng, S. Senan, Y.C. Ahn, T.-Y. Kim, H.K. Ahn, S. Peters, T. Yo
Annals of Oncology.2020; 31(2): 191. CrossRef
Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status
Soo Young Jeong, Hyea Park, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae, Chel Hun Choi
Cancer Research and Treatment.2020; 52(2): 516. CrossRef
Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
Mee-seon Kim, Eun Hee Lee, Moon-il Park, Jae Seok Lee, Kisu Kim, Mee Sook Roh, Hyoun Wook Lee
International Journal of Environmental Research and Public Health.2020; 17(5): 1726. CrossRef
From Genetic Testing to Treatment and Prevention of BRCA-Related Breast Cancer
Chang-Seok Ki
Annals of Laboratory Medicine.2020; 40(2): 99. CrossRef
Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells
Sun Tae Hwang, Jae-Young Um, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Acharan S. Narula, Ojas A. Namjoshi, Bruce E. Blough, Kwang Seok Ahn
Molecules.2020; 25(6): 1320. CrossRef
Current status of and trends in post-mastectomy breast reconstruction in Korea
Woo Jin Song, Sang Gue Kang, Eun Key Kim, Seung Yong Song, Joon Seok Lee, Jung Ho Lee, Ung Sik Jin
Archives of Plastic Surgery.2020; 47(02): 118. CrossRef
Identification of Dietary Pattern Networks Associated with Gastric Cancer Using Gaussian Graphical Models: A Case-Control Study
Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
Cancers.2020; 12(4): 1044. CrossRef
Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis
Kyeore Bae, Si Yeon Song
BMJ Open.2020; 10(5): e033461. CrossRef
Differential expressions of L1-chimeric transcripts in normal and matched-cancer tissues
Songmi Kim, Wonseok Shin, Yong-Moon Lee, Seyoung Mun, Kyudong Han
Analytical Biochemistry.2020; 600: 113769. CrossRef
Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study
Zhebin Du, Wei Chen, Qier Xia, Oumin Shi, Qi Chen
Biomarker Research.2020;[Epub] CrossRef
Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity
Sujin Kim, Wonki Kim, Do-Hee Kim, Jeong-Hoon Jang, Su-Jung Kim, Sin-Aye Park, Hyunggu Hahn, Byung Woo Han, Hye-Kyung Na, Kyung-Soo Chun, Bu Young Choi, Young-Joon Surh
Archives of Biochemistry and Biophysics.2020; 689: 108413. CrossRef
EGFR Fragmentation for Topological Transformation Nanobarcoding
Jeonghun Kim, Changhoon Yoo, Je Hun Moon, Soong Ho Um
ChemBioChem.2020; 21(17): 2533. CrossRef
BRAF and TERT promoter mutations: clinical application in thyroid cancer
Jae Hoon Chung
Endocrine Journal.2020; 67(6): 577. CrossRef
Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening
Do Yeun Kim, Hannah Lui Park
Journal of Breast Cancer.2020; 23(4): 331. CrossRef
Laparoscopic Surgery for Colorectal Cancer in Korea: Nationwide Data from 2013 to 2018
Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
Cancer Research and Treatment.2020; 52(3): 938. CrossRef
The Clinical Relevance and Function of Krüppel-Like Factor 16 in Breast Cancer

Soyeon Bang, Junhong Li, Meiqin Zhang, Renjie Cui, Xingwen Wu, Zhaochen Xin, Duan Ma, Jin Zhang, Hongwei Zhang
Cancer Management and Research.2020; Volume 12: 6373. CrossRef
Black Phosphorus Nanosheet with High Thermal Conversion Efficiency for Photodynamic/Photothermal/Immunotherapy
Danyang Xu, Jun Liu, Yanxing Wang, Yingying Jian, Weiwei Wu, Ruichan Lv
ACS Biomaterials Science & Engineering.2020; 6(9): 4940. CrossRef
Lung Cancer Incidence Prediction Using Machine Learning Algorithms
Kubra Tuncal, Boran Sekeroglu, Cagri Ozkan
Journal of Advances in Information Technology.2020; : 91. CrossRef
Epigenetic Role of Histone Lysine Methyltransferase and Demethylase on the Expression of Transcription Factors Associated with the Epithelial-to-Mesenchymal Transition of Lung Adenocarcinoma Metastasis to the Brain
Young Min Lee, Seok Hyun Kim, Minseok S. Kim, Dae Cheol Kim, Eun Hee Lee, Ju Suk Lee, Sung-Hun Lee, Young Zoon Kim
Cancers.2020; 12(12): 3632. CrossRef
Untargeted Metabolomics and Polyamine Profiling in Serum before and after Surgery in Colorectal Cancer Patients
Yu Ra Lee, Ki-Yong An, Justin Jeon, Nam Kyu Kim, Ji Won Lee, Jongki Hong, Bong Chul Chung
Metabolites.2020; 10(12): 487. CrossRef
Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer
Eun-Kyung Kim, Min-Jeong Song, Ho Hee Jang, Yoo Seung Chung
International Journal of Molecular Sciences.2020; 21(24): 9537. CrossRef
Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea
Se Ik Kim, Maria Lee, Sungyoung Lee, Dong Hoon Suh, Hee Seung Kim, Kidong Kim, Hyun Hoon Chung, Jae Hong No, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Yong Beom Kim
Gynecologic Oncology.2019; 155(1): 75. CrossRef
Epidemiology of liver cancer in Korea
Sun-Seog Kweon
Journal of the Korean Medical Association.2019; 62(8): 416. CrossRef
Neutrophil‐to‐lymphocyte ratio and risk of lung cancer mortality in a low‐risk population: A cohort study
Jihoon Kang, Yoosoo Chang, Jiin Ahn, Sukjoong Oh, Dong‐Hoe Koo, Yun‐Gyoo Lee, Hocheol Shin, Seungho Ryu
International Journal of Cancer.2019; 145(12): 3267. CrossRef
Relationship between Mothers' Diagnosis of Cervical Cancer and Attitudes toward Preventing Cervical Cancer in their Pubertal Daughters
Da Bit Lee, Hae Won Kim
Korean Journal of Women Health Nursing.2019; 25(4): 434. CrossRef
Female hormones and the risk of colorectal neoplasm
Yunho Jung
The Korean Journal of Internal Medicine.2019; 34(5): 982. CrossRef
Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials
Yan-Wen Liu, Ying Du, Bao-An Chen
Journal of International Medical Research.2019; 47(12): 5926. CrossRef
Dietary Inflammatory Index and Risk of Breast Cancer Based on Hormone Receptor Status: A Case-Control Study in Korea
Seohyun Lee, Arlene Lansangan Quiambao, Jeonghee Lee, Jungsil Ro, Eun-Sook Lee, So-Youn Jung, Mi-Kyung Sung, Jeongseon Kim
Nutrients.2019; 11(8): 1949. CrossRef
Does Holding Back Cancer-Related Concern Affect Couples' Marital Relationship and Quality of Life of Patients with Lung Cancer? An Actor–Partner Interdependence Mediation Modeling Approach
Soonyoung Oh, Eunjung Ryu
Asian Nursing Research.2019; 13(4): 277. CrossRef
Electro-Acupuncture Alleviates Cisplatin-Induced Anorexia in Rats by Modulating Ghrelin and Monoamine Neurotransmitters
Ji Yun Baek, Tuy An Trinh, Wonsang Huh, Ji Hoon Song, Hyun Young Kim, Juhee Lim, Jinhee Kim, Hyun Jin Choi, Tae-Hun Kim, Ki Sung Kang
Biomolecules.2019; 9(10): 624. CrossRef
Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker
Hun Jee Choe, Jin Won Kim, Song-Hee Han, Ju Hyun Lee, Sang-Hoon Ahn, Do Joong Park, Ji-Won Kim, Yu Jung Kim, Hye Seung Lee, Jee Hyun Kim, Hyung-Ho Kim, Keun-Wook Lee
Cancers.2019; 12(1): 86. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Prediction of Cancer Incidence and Mortality in Korea, 2019

Cancer Res Treat. 2019;51(2):431-437. Published online March 18, 2019

DOI: https://doi.org/10.4143/crt.2019.139

XML Download

Figure

Related articles

Prediction of Cancer Incidence and Mortality in Korea, 2019

Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2019. (A) Estimated new cases. (B) Estimated deaths.

Fig. 2. Projected age-specific incidences of major cancers during 2019 in Korea. (A) Male. (B) Female.

Fig. 3. Projected age-specific mortality rates of major cancers during 2019 in Korea. (A) Male. (B) Female.

Fig. 1.

Fig. 2.

Fig. 3.

Prediction of Cancer Incidence and Mortality in Korea, 2019

Site	Estimated new cases			Estimated deaths
Site	Both sexes	Male	Female	Both sexes	Male	Female
All sites	221,347	120,352	100,995	82,344	50,352	31,992
Lip, oral cavity, and pharynx	3,789	2,736	1,053	1,221	897	324
Esophagus	2,548	2,318	230	1,321	1,173	148
Stomach	27,175	18,039	9,136	6,729	4,349	2,380
Colon and rectum	25,330	14,478	10,852	8,653	4,813	3,840
Liver^a)	15,016	11,281	3,735	10,720	7,824	2,896
Gallbladder^b)	7,677	4,081	3,596	4,750	2,353	2,397
Pancreas	7,927	4,135	3,792	6,609	3,380	3,229
Larynx	1,095	1,035	60	292	292	0
Lung^c)	28,107	19,700	8,407	19,488	14,254	5,234
Breast	24,100	90	24,010	2,727	21	2,706
Cervix uteri	2,856	-	2,856	834	-	834
Corpus uteri	3,061	-	3,061	372	-	372
Ovary	2,832	-	2,832	1,271	-	1,271
Prostate	13,326	13,326	-	2,281	2,281	-
Testis	313	313	-	18	18	-
Kidney	5,609	3,794	1,815	1,189	816	373
Bladder	4,721	3,745	976	1,610	1,216	394
Brain and CNS	2,087	1,123	964	1,332	694	638
Thyroid	11,667	3,163	8,504	340	92	248
Hodgkin lymphoma	340	217	123	61	40	21
Non-Hodgkin lymphoma	5,264	3,046	2,218	2,051	1,182	869
Multiple myeloma	1,944	1,049	895	1,140	615	525
Leukemia	3,683	2,123	1,560	1,935	1,093	842
Other and ill defined	20,880	10,560	10,320	5,400	2,949	2,451

Site	Crude incidence rate per 100,000			Age-standardized incidence rate per 100,000^a)
Site	Both sexes	Male	Female	Both sexes	Male	Female
All sites	427.2	463.5	390.8	233.5	264.1	215.4
Lip, oral cavity, and pharynx	7.3	10.5	4.1	4.2	6.2	2.4
Esophagus	4.9	8.9	0.9	2.4	4.8	0.4
Stomach	52.5	69.5	35.4	27.1	38.8	16.9
Colon and rectum	48.9	55.8	42.0	24.2	30.9	18.4
Liver^b)	29.0	43.5	14.5	14.8	24.3	6.4
Gallbladder^c)	14.8	15.7	13.9	6.7	8.4	5.4
Pancreas	15.3	15.9	14.7	7.3	8.7	6.1
Larynx	2.1	4.0	0.2	1.1	2.1	0.1
Lung^d)	54.3	75.9	32.5	25.9	40.3	14.8
Breast	46.5	0.4	92.9	29.3	0.2	58.4
Cervix uteri	5.5	0.0	11.1	3.5	-	6.9
Corpus uteri	5.9	0.0	11.8	3.6	-	7.2
Ovary	5.5	0.0	11.0	3.4	-	6.8
Prostate	25.7	51.3	0.0	12.4	27.4	-
Testis	0.6	1.2	0.0	0.6	1.2	-
Kidney	10.8	14.6	7.0	6.2	8.8	3.8
Bladder	9.1	14.4	3.8	4.3	7.7	1.6
Brain and CNS	4.0	4.3	3.7	3.0	3.4	2.6
Thyroid	22.5	12.2	32.9	17.2	9.0	25.8
Hodgkin lymphoma	0.7	0.8	0.5	0.6	0.7	0.4
Non-Hodgkin lymphoma	10.2	11.7	8.6	6.3	7.8	5.0
Multiple myeloma	3.8	4.0	3.5	1.9	2.2	1.6
Leukemia	7.1	8.2	6.0	5.5	6.5	4.6
Other and ill defined	40.3	40.7	39.9	22.1	24.8	19.7

Rank	Age group (yr)
Rank	0-14	15-34	35-64	≥ 65
Male
1	Leukemia (5.0)	Thyroid (10.7)	Stomach (68.3)	Lung^a) (429.8)
2	Non-Hodgkin lymphoma (3.1)	Leukemia (3.7)	Colon and rectum (47.6)	Prostate (306.0)
3	Brain and CNS (2.3)	Non-Hodgkin lymphoma (3.2)	Liver^a) (47.0)	Stomach (287.8)
4	Kidney (0.4)	Testis (2.7)	Lung (43.8)	Colon and rectum (254.4)
5	Liver^b) (0.4)	Colon and rectum (2.3)	Prostate (25.9)	Liver^a) (163.1)
Female
1	Leukemia (4.3)	Thyroid (32.9)	Breast (157.2)	Colon and rectum (162.5)
2	Brain and CNS (1.9)	Breast (11.9)	Thyroid (45.9)	Lung^b) (119.5)
3	Non-Hodgkin lymphoma (1.7)	Cervix uteri (5.7)	Stomach (31.3)	Stomach (118.8)
4	Ovary (0.7)	Ovary (3.3)	Colon and rectum (29.7)	Breast (95.1)
5	Kidney (0.4)	Leukemia (2.4)	Lung^b) (25.4)	Gallbladder^c) (64.5)

Site	Crude mortality rate per 100,000			Age-standardized mortality rate per 100,000^a)
Site	Both sexes	Male	Female	Both sexes	Male	Female
All sites	158.9	193.9	123.8	71.9	102.7	49.4
Lip, oral cavity, and pharynx	2.4	3.5	1.3	1.1	1.9	0.5
Esophagus	2.6	4.5	0.6	1.1	2.3	0.2
Stomach	13.0	16.8	9.2	5.7	8.9	3.3
Colon and rectum	16.7	18.5	14.9	7.3	9.8	5.2
Liver^b)	20.7	30.1	11.2	9.8	16.3	4.2
Gallbladder^c)	9.2	9.1	9.3	3.7	4.6	3.1
Pancreas	12.8	13.0	12.5	5.8	7.0	4.7
Larynx	0.6	1.1	0.0	0.2	0.6	0.0
Lung^d)	37.6	54.9	20.3	16.2	28.0	7.5
Breast	5.3	0.1	10.5	3.0	0.0	5.7
Cervix uteri	1.6	-	3.2	0.8	-	1.6
Corpus uteri	0.7	-	1.4	0.4	-	0.7
Ovary	2.5	-	4.9	1.3	-	2.4
Prostate	4.4	8.8	-	1.7	4.5	-
Testis	0.0	0.1	-	0.0	0.1	-
Kidney	2.3	3.1	1.4	1.1	1.7	0.6
Bladder	3.1	4.7	1.5	1.2	2.4	0.5
Brain and CNS	2.6	2.7	2.5	1.6	1.8	1.4
Thyroid	0.7	0.4	1.0	0.3	0.2	0.3
Hodgkin lymphoma	0.1	0.2	0.1	0.1	0.1	0.0
Non-Hodgkin lymphoma	4.0	4.6	3.4	1.8	2.5	1.3
Multiple myeloma	2.2	2.4	2.0	1.0	1.3	0.8
Leukemia	3.7	4.2	3.3	2.0	2.6	1.6
Other and ill defined	10.4	11.4	9.5	4.9	6.3	3.8

Table 1. Estimated new cancer cases and deaths by sex during 2019 in Korea

CNS, central nervous system.

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the trachea, bronchus, and lung.

Table 2. Estimated crude and age-standardized cancer incidences by sex during 2019 in Korea

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the trachea, bronchus, and lung.

Table 3. Estimated cancer incidence by age group and sex during 2019 in Korea

CNS, central nervous system.

Includes the trachea, bronchus, and lung,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 4. Estimated crude and age-standardized cancer mortality rates by sex during 2019 in Korea

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the trachea, bronchus, and lung.